These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2121564)

  • 1. Fibrinolytic activity of oral cyclandelate in patients with generalized atherosclerotic vasculopathy: a double-blind study.
    Forconi S; Cappelli R; Guerrini M; Frigerio C; Messa GL; Furesi L
    J Int Med Res; 1990; 18(4):257-65. PubMed ID: 2121564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of plasma concentrations of cyclandelate and mandelic acid in patients with generalized atherosclerotic vasculopathy treated with oral cyclandelate.
    Forconi S; Cappelli R; Guerrini M; Volpi L; Frigerio C; Di Perri T
    J Int Med Res; 1990; 18(4):266-72. PubMed ID: 2227073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of haemostatic parameters in patients with acute cardioembolic stroke].
    Maksimova MIu; Domashenko MA; Ionova VG; Mikhal'chenko VN; Syskina EN; Okhtova FR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):22-7. PubMed ID: 22792744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
    Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
    Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D
    Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and gastric fibrinolysis in patients with gastric carcinoma.
    Prokopowicz J; Gabryelewicz A; Wołosowicz N; Szałaj W; Puchalski Z
    Z Exp Chir; 1975; 8(5):309-12. PubMed ID: 1053190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ; Boon GI; Jansen JW; Bouma BN
    Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study.
    Diener HC; Krupp P; Schmitt T; Steitz G; Milde K; Freytag S
    Cephalalgia; 2001 Feb; 21(1):66-70. PubMed ID: 11298666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. The Study group.
    Diener HC; Föh M; Iaccarino C; Wessely P; Isler H; Strenge H; Fischer M; Wedekind W; Taneri Z
    Cephalalgia; 1996 Oct; 16(6):441-7. PubMed ID: 8902255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals and in patients with chronic artery disease.
    Patrassi GM; Veronesi A; Sartori MT; Viero ML; Boeri G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):369-76. PubMed ID: 1703105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization.
    Martí-Fàbregas J; Borrell M; Cocho D; Martínez-Ramírez S; Martínez-Corral M; Fontcuberta J; Martí-Vilalta JL
    Stroke; 2008 Jan; 39(1):234-6. PubMed ID: 18048863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo-controlled study.
    Siniatchkin M; Gerber WD; Vein A
    Funct Neurol; 1998; 13(1):47-56. PubMed ID: 9584874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclandelate in the treatment of patients with mild to moderate primary degenerative dementia of the Alzheimer type or vascular dementia: experience from a placebo controlled multi-center study.
    Weyer G; Eul A; Milde K; Wierich W; Herrmann WM
    Pharmacopsychiatry; 2000 May; 33(3):89-97. PubMed ID: 10855459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on pharmacological enhancement of blood fibrinolytic activity.
    Gormsen J; Laursen B
    Angiology; 1970 Sep; 21(8):546-51. PubMed ID: 4990278
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin.
    Segal HC; Hunt BJ; Cottam S; Downing A; Beard C; Francis JL; Potter D; Tan KC
    Transplantation; 1994 Dec; 58(12):1356-60. PubMed ID: 7528949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclandelate in diabetic neuropathy. A double-blind, placebo-controlled, randomized, cross-over study.
    Heimans JJ; Drukarch B; Matthaei I; Ijff GA; Bertelsmann FW; Strijers RL; Nauta J
    Acta Neurol Scand; 1991 Dec; 84(6):483-6. PubMed ID: 1665271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclandelate on dementia.
    Westreich G; Alter M; Lundgren S
    Stroke; 1975; 6(5):535-8. PubMed ID: 1101457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.